PolyPid's regained European rights leave it free to pick a partner before the EMA's late-2027 decision, a choice that will shape its reach.
Why Is PolyPid Ltd. (PYPD) Stock Up Today?
Updated Nov 17, 2026 7:30 PM ET · Prev Close $6.15
Primary Move Catalyst & Conviction
68% Signal ConvictionUnusual Call buying detected
Options traders are heavily buying calls on PYPD, with 95% of volume in calls. This suggests bullish institutional positioning.
This stock is significantly outperforming its Medical Devices & Diagnostics sector peers, suggesting a stock-specific catalyst.
Market & Sector Relative Strength
PYPD outperforming the S&P 500 by +5.79%Options Flow & Execution Desk
Bullish Flow · P/C 0.19Recent PYPD Catalyst Headlines
Verified WireMoby summary of PolyPid Ltd.'s Q3 2026 earnings call
FDA labeling talks are underway ahead of the D-PLEX100 review deadline, with a potential U.S. launch in view.
PolyPid Ltd PYPD heads into a November 28, 2026 PDUFA date with labeling talks underway, a 30 million Azurity partnership already paying off, and cash runway into 2028.
1–3 Day Expected Range & Key Level
65% Follow-ThroughWatch for continuation above $6.45
Technical Regime (PYPD)
BULLISH MA TREND1-Year Historical Move Analogs
48 EventsSessions in the past year where PYPD moved >3.0% up:
Retail & Crowd Sentiment
Very BullishTraders on StockTwits express bullish sentiment towards $PYPD, anticipating FDA approval and potential stock price increase. No new news articles were found.
About PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on Plex (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized dru...
Get Instant PYPD Catalyst Alerts
Receive an email alert when PYPD triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversPYPD Session & Catalyst FAQ
Why is PYPD stock up today?
Options traders are heavily buying calls on PYPD, with 95% of volume in calls. This suggests bullish institutional positioning.
Is PYPD stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 3.78x relative volume (high participation). Our multi-factor model currently rates PYPD as AVOID NEW MONEY. Review full valuation, quality, and timing signals on the PYPD Buy or Sell Decision Brief →
What is PYPD's intrinsic value and expected trading range?
At $6.45, PYPD's modeled 1-to-3 session range is $6.32 – $6.64, with a key inflection level at $6.77 (resistance). Compare current price against multi-year cash flow projections in the PYPD Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for PYPD?
RSI at 63.2 reflects constructive bullish momentum. PYPD trades at $6.45 relative to its 20-day SMA ($5.80) and 50-day SMA ($5.40), reflecting a bullish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.